Kastritis, E. et al. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis.
Systemic light chain (AL) amyloidosis is the most common of these conditions, but wild-type transthyretin cardiac amyloidosis (ATTRwt) is increasingly being diagnosed.
Liver may play an important role in the COPD systemic inflammation chain [37].
Literature also reports that systemic short chain fatty acids can up regulate the expression of early response genes such as c-Myc, c-Fos and c-Jun [106].
Systemic light chain (AL) amyloidosis presents unique challenges both in understanding the biology and for the therapy of the affected individuals.
Comenzo RL, Reece D, Palladini G, Seldin D, Sanchorawala V, Landau H, Falk R, Wells K, Solomon A, Wechalekar A, Zonder J, Dispenzieri A, Gertz M, Streicher H, Skinner M, Kyle RA, Merlini G. Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosis.
These diseases can be divided by localized (Alzheimer's disease (AD)) or systemic (light-chain amyloidosis (AL)) deposition.
Ixazomib has also been evaluated in other phase 1 dose-escalation studies using different dosing schedules (weekly or twice-weekly), different routes of administration (IV or oral), and in different patient populations (multiple myeloma (MM), systemic light-chain amyloidosis, or solid tumors).
Systemic and supply chain issues have no simple fix, but a groundswell of grassroots consumer interest marks a defining moment.
Patients with systemic amyloid light chain amyloidosis were also excluded from analysis owing to its impact on survival.
